(Q43982800)

28 November 2017

title

Efficacy and safety of rosiglitazone plus metformin in Mexicans with type 2 diabetes (English)

1 reference

28 November 2017

1 reference

1 reference

1 reference

Francisco J Gómez-Perez

1

1 reference

28 November 2017

Guillermo Fanghänel-Salmón

2

1 reference

28 November 2017

Juan Antonio Barbosa

3

1 reference

28 November 2017

Juan Montes-Villarreal

4

1 reference

28 November 2017

Rhona A Berry

5

1 reference

28 November 2017

Ghulam Warsi

6

1 reference

28 November 2017

Errol M Gould

7

1 reference

28 November 2017

publication date

1 March 2002

1 reference

Diabetes - Metabolism: Research and Reviews

28 November 2017

published in

1 reference

28 November 2017

volume

18

1 reference

28 November 2017

issue

2

1 reference

28 November 2017

page(s)

127-134

1 reference

Association of Differing Dietary, Metabolic, and Clinical Risk Factors with Macrovascular Complications of Diabetes: A Prevalence Study of 503 Mexican Type II Diabetic Subjects. I

28 November 2017

cites work

1 reference

Association of differing dietary, metabolic, and clinical risk factors with microvascular complications of diabetes: a prevalence study of 503 Mexican type II diabetic subjects. II.

21 January 2018

1 reference

Genetic and Environmental Determinants of Type II Diabetes in Mexico City and San Antonio

21 January 2018

1 reference

Rapid rise in the incidence of type 2 diabetes from 1987 to 1996: results from the San Antonio Heart Study.

21 January 2018

1 reference

Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study

21 January 2018

1 reference

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

21 January 2018

1 reference

[[omega-(Heterocyclylamino)alkoxy]benzyl]-2,4-thiazolidinediones as potent antihyperglycemic agents

21 January 2018

1 reference

Rosiglitazone monotherapy improves glycaemic control in patients with type 2 diabetes: a twelve-week, randomized, placebo-controlled study.

21 January 2018

1 reference

Rosiglitazone taken once daily provides effective glycaemic control in patients with Type 2 diabetes mellitus.

21 January 2018

1 reference

Rosiglitazone short-term monotherapy lowers fasting and post-prandial glucose in patients with type II diabetes.

21 January 2018

1 reference

Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.

21 January 2018

1 reference

Metabolic effects of metformin in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients

21 January 2018

1 reference

Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial.

21 January 2018

1 reference

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

21 January 2018

1 reference

Hyperglycemia and microvascular and macrovascular disease in diabetes

21 January 2018

1 reference

Long-term glycemic control relates to mortality in type II diabetes.

21 January 2018

1 reference

Rosiglitazone monotherapy is effective in patients with type 2 diabetes

21 January 2018

1 reference

Cardiovascular risk factors clustering with endogenous hyperinsulinaemia predict death from coronary heart disease in patients with Type II diabetes.

21 January 2018

1 reference

Insulin resistance as an independent risk factor for carotid artery wall intima media thickening in vasospastic angina.

21 January 2018

1 reference

Epidemiologic aspects of lipid abnormalities

21 January 2018

1 reference

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

21 January 2018

1 reference

Central role of the adipocyte in insulin resistance

21 January 2018

1 reference

Fatty acids, lipotoxicity and insulin secretion

21 January 2018

1 reference

Nonhypoglycemic effects of thiazolidinediones

21 January 2018

1 reference

Cholesterol and coronary heart disease: predicting risks by levels and ratios

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Role of non-esterified fatty acids in the pathogenesis of type 2 diabetes mellitus

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/DMRR.264

1 reference

28 November 2017

1 reference